FIELD: pharmacology.
SUBSTANCE: preparation containing a tincture of European madder root, magnesium salicylate, essential oils with a set of active substances, ethyl alcohol and vegetable oil is proposed, the composition further comprises a mixture of linoleic and linolenic acids, castor oil as a vegetable oil, eucalyptus essential oil, anise essential oil and fennel essential oil as essential oils, and 1,8-cineole eucalyptus essential oil as a biologically active substance of essential oils a at certain ratio of the composition ingredients.
EFFECT: pronounced therapeutic effect in destruction and excretion of urinary stones, pronounced anti-inflammatory and diuretic effects.
2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG WITH SPASMOLITHIC, DIURETIC AND LITHIOLIC ACTION | 2017 |
|
RU2635459C1 |
| ANTISPASMODIC, DIURETIC AND ANTI-INFLAMMATORY DRUG (VERSIONS) | 2024 |
|
RU2836881C1 |
| ANTISPASMODIC, ANTIULCER AND ANTACID AGENT | 2021 |
|
RU2784057C1 |
| SPRAY FOR EMERGENCY PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2017 |
|
RU2665959C1 |
| AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
| COMPOSITION FOR TOPICAL APPLICATION IN THE TREATMENT OF ONYCHOMYCOSIS (OPTIONS) | 2022 |
|
RU2786851C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
